ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality (ACM) and frequency of cardiovascular-related hospitalization (CVH)), with a Win Ratio of 1.8 (p<0.0001)
January 12, 2024
BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine
January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and…
Read More
An unprecedented collaboration between an eminent heart surgeon, a Michelin-starred chef and a global cardiovascular device provider sees the launch of a unique, surgically inspired recipe book, conceived to help surgeons practice their surgical dexterity in an unexpected way
January 12, 2024
A World-first Collaboration to Help Heart Surgeons Utilize Their Dexterity in an Unexpected Way – Introducing The Heart Surgeon’s Cookbook
January 12, 2024 — The Heart Surgeon’s Cookbook is the brainchild of New York-based Cardiovascular and Thoracic Surgeon…
Read More
January 11, 2024
WEBINAR NOW AVAILABLE ON DEMAND: Contrast Management in Modern PCI
On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on  "Contrast Management in Modern PCI…
Read More
It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of Bruce Wilkoff, MD, FHRS
January 11, 2024
In Memoriam: Bruce Wilkoff, MD, FHRS
January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned…
Read More
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft Dysfunction (PGD), a severe post-transplant complication ― potentially allowing for an increase in donor hearts available for heart transplant patients
January 11, 2024
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study
January 11, 2024 — Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the…
Read More
The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups.
January 11, 2024
Chung-Ang University Study Looks at Cardiovascular Risks in COVID-19 Survivors
January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia…
Read More
82-year-old man with calcified stenosis in left main artery who underwent coronary CTA by PCD CT
January 11, 2024
Photon-Counting Detector CT Virtual Monoenergetic Images for Coronary Artery Stenosis Open configuration options
January 11, 2024 — According to the American Journal of Roentgenology (AJR), photon-counting detector (PCD) CT with…
Read More
The roundtable focused on the current challenges in diagnosing and treating lower extremity revascularization, knowledge and data gaps, and the potential role of IVUS in addressing these challenges
January 09, 2024
SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable
January 9, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular…
Read More
New research from Mayo Clinic suggests that AI could improve the diagnosis of peripartum cardiomyopathy
January 09, 2024
Clinical Research Shows AI-enabled Digital Stethoscope can Detect Pregnancy-related Heart Disease
January 9, 2024 — New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis…
Read More
FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia
January 09, 2024
Cleerly Launches Cleerly ISCHEMIA Solution for Heart Disease Analysis
January 9, 2024 — Cleerly, the company working to create a new standard of care for the diagnosis of heart disease,…
Read More
Medtronic recently launched Penditure system for patients needing left atrial appendage closure
January 08, 2024
UH Harrington Heart and Vascular Institute First in World to Implant Penditure Clip Using Minimally Invasive Approach
January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center…
Read More
Physicians at Vilnius University.
January 08, 2024
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
January 8, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention,…
Read More
The potential acquisition is part of GE HealthCare’s precision care strategy, which is focused on helping to deliver more precise, connected, and efficient care across disease states. GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
January 08, 2024
GE HealthCare Announces Agreement to Acquire MIM Software
January 8, 2024 — GE HealthCare announced it has entered into an agreement to acquire MIM Software, a global provider…
Read More
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership
January 05, 2024
Medtronic Receives CE Mark for its Next Generation Micra Leadless Pacing Systems
January 5, 2024 — Medtronic, a global leader in healthcare technology, today announced it has received CE (Conformité…
Read More
Diagnostic and Interventional Cardiology
By Melinda Taschetta-Millane
January 05, 2024
2023 in Review: A Look at the Year's Top 10 Topics
As the Diagnostic and Interventional Cardiology (DAIC) team welcomes in the New Year, we also have taken a few moments…
Read More
Five implants successfully accomplished at the Instituto Nacional de Torax in Santiago, Chile with advanced engineered heart valve, ZETA, designed to provide flexibility and optionality regardless of high, low or zero calcification
January 04, 2024
Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial
January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural…
Read More
Study in American Journal of Critical Care finds allowing patients to eat a heart-healthy diet prior to cardiac catheterization posed no safety risk, improved their satisfaction
January 04, 2024
Fasting Before Cardiac Catheterization May Be Unnecessary
January 4, 2024 — The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of…
Read More
Study investigators Drs. Pedro Engel-Gonzalez and Gennaro Giustino from Henry Ford Health.
January 04, 2024
Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure
January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart…
Read More
Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a know-how agreement with Mayo Clinic on the development of a cardiac clinical AI solution with the intent to prevent premature deaths from heart disease and stroke.
January 03, 2024
K Health to Collaborate with Mayo Clinic on Cardiac Clinical Artificial Intelligence (AI) Solution
January 4, 2024 — Artificial Intelligence (AI)-driven Primary Care company K Health has announced it has entered into a…
Read More
CE mark reinforces the Zio monitor system as a leading innovation in ambulatory cardiac monitoring and highlights the company’s commitment to providing the highest quality product and services globally
January 03, 2024
iRhythm Technologies Receives European Union’s CE Marking Under Medical Device Regulation (EU MDR) for its Zio monitor and ZEUS System
January 3, 2024 — iRhythm Technologies, Inc., a leading digital health care company focused on creating trusted…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now